Skip to search.
 BSE Down 2.23% NSE Down 2.33%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
48.75 Down 1.43(2.85%) 1:30am
|After Hours : 48.91 Up 0.16 (0.33%) 3:03am
Add to Portfolio
Prev Close:50.18
Open:49.01
Bid:48.34 x 200
Ask:49.20 x 200
1y Target Est:65.00
Beta:2.22577
Earnings Date:5 Nov - 9 Nov (Est.)
Day's Range:48.15 - 49.62
52wk Range:35.26 - 77.80
Volume:2,162,752
Avg Vol (3m):2,199,460
Market Cap:5.85B
P/E (ttm):256.58
EPS (ttm):0.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ISIS at this time.

Comparison

Symbol% ChgMkt Cap
ISISDown 2.85%5.85B
GILDDown 3.41%148.95B
ENZDown 1.03%133.11M
SRPTDown 1.37%1.46B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.52
Quarterly EPS Est (Sep-15) :-0.31
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-4.31

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback